Comparison of the Robustness of Spectrophotometric Method and High-Performance Liquid Chromatographic Method for the Determination of Pioglitazone in Solid Dosage Form
Sara Zahid *
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan.
Fatima Zahid
Faculty of Pharmacy, The University of Lahore-Islamabad, Pakistan.
Asma Ahmed
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan.
Waqas Safir
Department of Biochemistry, Hazara University Mansehra, Pakistan.
*Author to whom correspondence should be addressed.
Abstract
Pioglitazone is a drug that reduces the amount of glucose (sugar) in the blood. It is included in the class of anti-diabetic drugs called “thiazolidinedione” that are used in the treatment of type II diabetes. It attaches to the peroxisomes proliferated- activated receptor gamma (PPARϒ) on tissues throughout the body and causes the cells to become more sensitive to insulin. As a result, more glucose is removed from the blood.The aim of the study is more precisely to find out the better analytical method for the quantitative measurement of the content of pioglitazone in commercially available drugs using two analytical methods i-e Spectrophotometric method and HPLC method.The analytical method for the pioglitazone hydrochloride was developed by HPLC, and then validated the method according to compendial requirements. Pioglitazone in various Dowglit and Gliden tablets was determined by this developed methodPrecision, Accuracy and stability of Pioglitazone was checked which came out to be100.40% and 100.19% respectively. The analysis of pioglitazone hydrochloride in solid dosage form using the HPLC method shows the results are more sensitive, accurate, validated and economical and can be easily applied to raw materials and finished goods compared to the Spectrophotometer method.
Keywords: Pioglitazone, HPLC, spectrophotometer, proliferated, insulin, anti-diabetic drugs